MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells | |
Ma, Zhongliang[1]; Qiu, Xiang[2]; Wang, Detao[3]; Li, Yanli[4]; Zhang, Bingjie[5]; Yuan, Tianwei[6]; Wei, Jiali[7]; Zhao, Botao[8]; Zhao, Xintai[9]; Lou, Jiatao[10] | |
刊名 | ACTA BIOCHIMICA ET BIOPHYSICA SINICA |
2015 | |
卷号 | 47页码:630-638 |
关键词 | miR-181a-5p proliferation migration non-small cell lung cancer |
ISSN号 | 1672-9145 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2269496 |
专题 | 上海大学 |
作者单位 | 1.[1]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 2.[2]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 3.[3]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 4.[4]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 5.[5]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 6.[6]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 7.[7]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 8.[8]Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China. 9.[9]Shanghai Shines Pharmaceut Co Ltd, Shanghai 200032, Peoples R China. 10.[10]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Lab Med, Shanghai 200030, Peoples R China. |
推荐引用方式 GB/T 7714 | Ma, Zhongliang[1],Qiu, Xiang[2],Wang, Detao[3],et al. MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells[J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA,2015,47:630-638. |
APA | Ma, Zhongliang[1].,Qiu, Xiang[2].,Wang, Detao[3].,Li, Yanli[4].,Zhang, Bingjie[5].,...&Jin, Youxin[12].(2015).MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.ACTA BIOCHIMICA ET BIOPHYSICA SINICA,47,630-638. |
MLA | Ma, Zhongliang[1],et al."MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells".ACTA BIOCHIMICA ET BIOPHYSICA SINICA 47(2015):630-638. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论